Global Plasma Protein Therapeutics Market To Reach $28.11 Billion In 2023, Driven By Product Innovations And Increasing Prevalence Of Autoimmune Disorders

DUBLIN, July 20, 2023 /PRNewswire/ -- The "Plasma Protein Therapeutics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

The market is projected to grow from $26.25 billion in 2022 to $28.11 billion in 2023, with a compound annual growth rate (CAGR) of 7.1%. Furthermore, the market is expected to reach $35.84 billion by 2027, exhibiting a CAGR of 6.3%.

Major players in the plasma protein therapeutics market include Octapharma AG, CSL Behring LLC, Grifols S.A, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion S.p.A., Shire PLC., LFB GROUP, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions B.V., Bio Products Laboratory Ltd., and MP Biomedicals LLC.

Reasons to Purchase:

• Gain a comprehensive global perspective with detailed coverage of 50+ geographies.
• Understand the market's response to COVID-19 and its impact as the virus abates.
• Assess the direct and indirect effects of the Russia-Ukraine war on agriculture, energy, mineral commodity supply, and the market.
• Measure the influence of high global inflation on market growth.
• Develop regional and country-specific strategies based on localized data and analysis.
• Identify investment opportunities in growth segments.
• Outperform competitors using forecast data and insights into market drivers and trends.
• Understand customer dynamics based on the latest market shares.
• Benchmark performance against key competitors.
• Support internal and external presentations with reliable high-quality data and analysis.

Plasma protein therapeutics are therapies derived from plasma and their recombinant analogs. These therapies replace missing or deficient proteins found in plasma, enabling recipients to live healthier lives. The main products in the plasma protein therapeutics market include immunoglobulin, albumin, coagulation factors, C1-esterase inhibitors, and other products. These products are used for various applications such as primary immunodeficiency disorders, idiopathic thrombocytopenic purpura, secondary immunodeficiency, hereditary angioedema, and more.

Product innovations are driving the plasma protein therapeutics market, with major players focusing on developing innovative products to gain a competitive advantage. These innovations help expand product portfolios, improve patient access to plasma therapies, and drive revenue growth. For example, Grifols S.A. acquired Tiancheng (Germany) Pharmaceutical Holdings AG in April 2022, which is expected to accelerate Grifols' product portfolio expansion and revenue growth.

North America accounted for the largest share of the plasma protein therapeutics market in 2022, while the Asia-Pacific region is expected to witness significant growth. The regions covered in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Key countries analyzed in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The increasing prevalence of autoimmune disorders is expected to drive the growth of the plasma protein therapeutics market. Autoimmune disorders occur when the body's immune system mistakenly attacks and destroys healthy cells. Therapeutic plasma exchange using plasma protein therapeutics is used to treat autoimmune diseases, which occur when the body produces autoantibodies that attack its own tissues.

The plasma protein therapeutics market includes revenues earned by entities providing therapies for liver disease and bleeding from trauma, using products such as Alpha-1 Proteinase Inhibitors and Hyperimmune Globulins. The market value encompasses the value of goods and services sold by the service providers. Only goods and services traded between entities or sold to end consumers are included.

Key Topics Covered:



1. Executive Summary



2. Plasma Protein Therapeutics Market Characteristics



3. Plasma Protein Therapeutics Market Trends And Strategies



4. Plasma Protein Therapeutics Market - Macro Economic Scenario

4.1. COVID-19 Impact On Plasma Protein Therapeutics Market

4.2. Ukraine-Russia War Impact On Plasma Protein Therapeutics Market

4.3. Impact Of High Inflation On Plasma Protein Therapeutics Market



5. Plasma Protein Therapeutics Market Size And Growth

5.1. Global Plasma Protein Therapeutics Historic Market, 2017-2022, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Plasma Protein Therapeutics Forecast Market, 2022-2027F, 2032F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market



6. Plasma Protein Therapeutics Market Segmentation

6.1. Global Plasma Protein Therapeutics Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Immunoglobulin
• Albumin
• Coagulation Factor
• C1-esterase Inhibitors
• Other Products

6.2. Global Plasma Protein Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Intravenous
• Subcutaneous

6.3. Global Plasma Protein Therapeutics Market, Segmentation By Applications, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

• Primary Immunodeficiency Disorder (PID)
• Idiopathic Thrombocytopenic Purpura
• Secondary Immunodeficiency
• Hereditary Angioedema
• Other Applications

7. Plasma Protein Therapeutics Market Regional And Country Analysis

7.1. Global Plasma Protein Therapeutics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

7.2. Global Plasma Protein Therapeutics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/q9kp2l

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/global-plasma-protein-therapeutics-market-to-reach-28-11-billion-in-2023--driven-by-product-innovations-and-increasing-prevalence-of-autoimmune-disorders-301882232.html

SOURCE Research and Markets